$4.56
0.122.70%
At Close: -
$4.46
-0.1-2.19%
After Hours: Aug 23, 8:48 AM EDT
15 minutes delayed
Eagle Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eagle Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-08 | $1.18 | $1.05 | 12.4 % |
Mar 2023 | 2023-05-09 | $1.26 | $1.05 | 20.0 % |
Dec 2022 | 2023-03-13 | $1.10 | $0.83 | 32.5 % |
Sep 2022 | 2022-11-07 | $1.12 | $0.91 | 23.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-08 | $64.65M | $59.35M | 8.92 % |
Mar 2023 | 2023-05-09 | $66.31M | $63.29M | 4.76 % |
Dec 2022 | 2023-03-13 | $60.70M | $64.26M | -5.54 % |
Sep 2022 | 2022-11-07 | $65.90M | $62.08M | 6.15 % |
Eagle Pharmaceuticals (EGRX) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.
The Actual EPS was $0.00, which missed the estimate of $1.07.
The Actual Revenue was $0K, which missed the estimate of $64.5M.
Browse earnings estimates, EPS, and revenue on all stocks.